Maker Faire Rome: a firing of minds and a launch of innovation.
Exhibitors 2023
- ART
- ARTISANS & NEW CRAFT
- FASHION & WEARABLES
- RECYCLING & UPCYCLING
- STEAM PUNK
- CIRCULAR ECONOMY
- PRODUCT DESIGN
- STARTUP
- BIOLOGY
- EDUCATION
- MUSIC & SOUND
- SCIENCE
- GAMES
- HACKS
- INTERNET OF THINGS
- OPEN SOURCE
- HOME AUTOMATION
- FABRICATION
- NEW MANUFACTURING
- ROBOTICS
- INDUSTRIAL AUTOMATION
- 3D PRINTING
- ENERGY & SUSTAINABILITY
- YOUNG MAKERS (< 18)
- WELLNESS & HEALTHCARE
- AEROSPACE
- FOOD & AGRICULTURE
- 3D SCANNING
- ARTIFICIAL INTELLIGENCE
- DRONES
- KIDS & EDUCATION
- CULTURAL HERITAGE
- RETROCOMPUTING
- VIRTUAL REALITY
- CYBERSECURITY
Organoidi: avatar 3D per conoscere e curare i tumori.
Tumor organoids are 3D experimental models derived from cancer cells that recapitulate the characteristics of their tissues of origin. Organoid models offer insights into all aspects covering tumor development, progression and response to the treatment of tissue obtained from individual patients. Therefore, tumor organoids can be used as personalized avatars for translational studies aimed at improving precision oncology.
At our Institute there are several studies ongoing dedicated to the generation and use of tumor organoids as a surrogate for the evaluation of the efficacy of different therapeutic approaches.
G. Blandino, S. Strano, S. Donzelli C.Pulito, C.Frascolla, S. Vaccarella, D.Rutigliano, R. Brandi
Giovanni Blandino, director of Translational Oncology Research Unit, promotes the development of translational research studies using organoids as preclinical models for cancer.
Sabrina Strano is a senior researcher that supports all group’s research activity.
Sara Donzelli and Claudio Pulito are researchers with extensive experience in establishing tumor organoids for preclinical drug screening.
Carlotta Frascolla, Sebastiano Vaccarella, Daniela Rutigliano, and Renata Brandi are young researcher involved in multiple research projects for generating and characterizing tumor organoids.
